Covidien Reports Fourth-Quarter and Fiscal 2009 Results
September 2009). Excluding the comparison of $57 million in fourth-quarter 2008 sales of oxycodone hydrochloride extended-release tablets (Oxy ER), fourth-quarter 2009 operational growth (net sales growth excluding the effect...



